Saturday 17 October 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024. In the quarter to June 2026, revenue grew 66.9%, EPS grew 341.2%, free cash flow grew 152.8% and total debt fell 1.51%, each against the same quarter a year earlier. Member of the Nasdaq 100; revenue growth for five consecutive years.

231.83 2.20 −0.94%

Follow ALNY

Alert me

Market cap: $31.3B
P/E: 39.5×
Fwd P/E: 39.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	51.30	80.14	163.12	748.40	+8 more quarters Free account
P/S ratio Full definition →	8.37	10.26	14.03	18.67
P/FCF ratio Full definition →	49.06	68.35	111.94	270.78
P/Operating CF Full definition →	123.10	623.66	318.51	170.75
P/B ratio Full definition →	29.70	40.89	66.01	256.27
Price to Tangible BV Full definition →	29.70	40.89	66.01	256.27
EV/Sales Full definition →	7.89	9.79	13.51	18.15
EV/EBITDA Full definition →	35.96	52.01	90.08	181.47
EV/Operating CF Full definition →	41.59	58.71	95.77	219.12
EV/FCF Full definition →	46.25	65.24	107.85	263.17
Quick Ratio Full definition →	2.79	2.89	2.51	2.37
Current Ratio Full definition →	3.05	3.13	2.76	2.54
Net Debt/EBITDA Full definition →	(9.36)	(7.09)	(13.09)	(4.41)
Debt/Assets Full definition →	18.19%	19.68%	20.29%	21.44%
Debt/Equity Full definition →	0.75	0.94	1.28	4.45
Asset Turnover Full definition →	0.95	0.92	0.81	0.71
Operating CF/Net income Full definition →	1.99	0.34	1.07	1.40
Capex/Depreciation Full definition →	(2.50)	(1.61)	(1.72)	(0.88)
Interest Coverage Full definition →	2.82	3.88	1.49	8.29
Research and Development Expense of Revenue Full definition →	32.00%	31.26%	33.93%	28.73%
Selling, General and Administrative Expense of Revenue Full definition →	26.95%	27.64%	29.66%	25.79%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	6.71%	6.01%	6.53%	8.66%
Graham Net Nets Full definition →	0.01	0.00	0.00	(0.01)
Graham Number Full definition →	36.58	27.42	18.18	4.94
Earnings Yield Full definition →	1.95%	1.25%	0.61%	0.13%
Free Cash Flow Yield Full definition →	2.04%	1.46%	0.89%	0.37%
Revenue per Share Full definition →	9.66	8.78	8.37	9.50
Operating CF per Share Full definition →	2.45	0.53	1.25	2.67
Capex per Share Full definition →	(0.26)	(0.16)	(0.18)	(0.09)
Free Cash Flow per Share Full definition →	2.19	0.37	1.07	2.58
Cash per Share Full definition →	24.76	22.64	22.20	20.73
Shareholders Equity per Share Full definition →	10.14	8.09	6.02	1.78
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	10.14	8.09	6.02	1.78
Free Cash Flow Full definition →	292.04	48.67	140.26	338.89
Working Capital Full definition →	3,107.66	2,869.83	2,584.31	2,397.33
Capital Expenditures Full definition →	(34.68)	(21.83)	(23.29)	(12.14)
Net Current Asset Value Full definition →	415.52	165.14	(126.49)	(664.96)
EV/EBIT Full definition →	37.93	55.80	100.07	220.08
Capex to Sales Full definition →	0.03	0.02	0.02	0.01
Price to Operating Income Full definition →	40.23	58.46	103.86	226.44
Other line items
Average Receivables Full definition →	739.93	651.00	591.44	659.31
Average Payables Full definition →	105.20	112.01	102.07	94.20
Average Inventory Full definition →	84.40	74.80	80.61	75.69
Average Assets Full definition →	5,062.39	4,671.68	4,603.16	4,528.35
Average Common Equity Full definition →	802.35	595.41	428.13	133.12

Show all line items

Columns are period end dates

Stockrow Weekly